A Combination Strategy for Pyrrole-Containing Alkaloids

Information

  • Research Project
  • 6848378
  • ApplicationId
    6848378
  • Core Project Number
    R15CA067236
  • Full Project Number
    2R15CA067236-03
  • Serial Number
    67236
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/1/1996 - 28 years ago
  • Project End Date
    1/31/2008 - 16 years ago
  • Program Officer Name
    LEES, ROBERT
  • Budget Start Date
    1/1/2005 - 19 years ago
  • Budget End Date
    1/31/2008 - 16 years ago
  • Fiscal Year
    2005
  • Support Year
    3
  • Suffix
  • Award Notice Date
    12/22/2004 - 19 years ago
Organizations

A Combination Strategy for Pyrrole-Containing Alkaloids

DESCRIPTION (provided by applicant): This proposal represents a continuation of work initiated under NIH AREA grant CA67236-02, which began July 1, 2001 and will end July 31,2004. The previous proposal focused on using 3-substituted or 2,3- disubstituted beta-chloroenals as key synthons for the regioselective preparation of pyrroles, which could function as precursors to appropriate, bioactive, marine natural products or might exhibit interesting bioactivity of their own. Alkaloids, which belong to this rapidly growing family of pyrrole containing marine natural products, exhibit anti-tumor, anti-HIV, immunomodulatory and multidrug resistance (MDR) reversal activities and are under current investigation by a significant number of research groups. Interestingly, studies in our group during the last several years indicate that further elaboration at the 5 position of these 2,3,4-trisubstituted pyrroles is quite challenging, with the exception of the bromination at the 5 position with NBS. In addition, the desire to create a rapid and diverse group of analogs for biological evaluation prompted us to consider some previous work in our laboratory. We have demonstrated that symmetrical vinamidinium salts can be readily and efficiently prepared and condensed with glycinate esters to give 2-carboalkoxy-4- substituted pyrroles in high yields. Our new strategy involves the electrophilic substitution of the 2,4- disubstituted pyrroles at the 5 position. This is followed by bromination with NBS at the 4-position and then a cross-coupling reaction (Suzuki or Heck type) to give the tetrasubstituted core, which can be further elaborated to the desired pyrroles. The targets of this methodology will initially be the marine natural products Polycitone A and B, Rigidins A-D, Permethyl Storniamide, Ningalin A and their analogs. In this manner, a large, flexable and regioselective array of pyrroles can be rapidly assembled. All of the target molecules, their precursors and their analogs will subsequently be bioassayed by collaborators and/or the NCI. Mode of action and structure activity relationships will also be examined (in conjunction with collaborators) as part of this project.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R15
  • Administering IC
    CA
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    190980
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NCI:190980\
  • Funding Mechanism
  • Study Section
    MCHA
  • Study Section Name
    Medicinal Chemistry Study Section
  • Organization Name
    UNIVERSITY OF RICHMOND
  • Organization Department
    CHEMISTRY
  • Organization DUNS
    056915069
  • Organization City
    RICHMOND
  • Organization State
    VA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    23173
  • Organization District
    UNITED STATES